US6174999B1
(en)
*
|
1987-09-18 |
2001-01-16 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6235726B1
(en)
*
|
1987-09-18 |
2001-05-22 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6610669B1
(en)
*
|
1987-09-18 |
2003-08-26 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US5527893A
(en)
*
|
1987-09-18 |
1996-06-18 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6030958A
(en)
*
|
1987-09-18 |
2000-02-29 |
Genzyme Corporation |
Water insoluble derivatives of hyaluronic acid
|
IT1219587B
(it)
*
|
1988-05-13 |
1990-05-18 |
Fidia Farmaceutici |
Polisaccaridi carbossiilici autoreticolati
|
US5510418A
(en)
*
|
1988-11-21 |
1996-04-23 |
Collagen Corporation |
Glycosaminoglycan-synthetic polymer conjugates
|
US5356883A
(en)
*
|
1989-08-01 |
1994-10-18 |
Research Foundation Of State University Of N.Y. |
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
|
US5234914A
(en)
*
|
1991-06-11 |
1993-08-10 |
Patent Biopharmaceutics, Inc. |
Methods of treating hemorrhoids and anorecial disease
|
EP0544259A1
(en)
*
|
1991-11-27 |
1993-06-02 |
Lignyte Co., Ltd. |
Water insoluble biocompatible hyaluronic and polyion complex and method of making the same
|
CA2072918A1
(en)
*
|
1992-02-14 |
1993-08-15 |
Jian Qin |
Modified polysaccharides having improved absorbent properties and process for the preparation thereof
|
US5633001A
(en)
*
|
1993-03-19 |
1997-05-27 |
Medinvent |
Composition and a method for tissue augmentation
|
US5616568A
(en)
*
|
1993-11-30 |
1997-04-01 |
The Research Foundation Of State University Of New York |
Functionalized derivatives of hyaluronic acid
|
ITPD940054A1
(it)
*
|
1994-03-23 |
1995-09-23 |
Fidia Advanced Biopolymers Srl |
Polisaccaridi solfatati
|
US5585361A
(en)
|
1994-06-07 |
1996-12-17 |
Genzyme Corporation |
Methods for the inhibition of platelet adherence and aggregation
|
US5931165A
(en)
*
|
1994-09-06 |
1999-08-03 |
Fusion Medical Technologies, Inc. |
Films having improved characteristics and methods for their preparation and use
|
US6294202B1
(en)
*
|
1994-10-06 |
2001-09-25 |
Genzyme Corporation |
Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
|
US6063396A
(en)
*
|
1994-10-26 |
2000-05-16 |
Houston Biotechnology Incorporated |
Methods and compositions for the modulation of cell proliferation and wound healing
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
US5498705A
(en)
*
|
1995-02-22 |
1996-03-12 |
Kimberly-Clark Corporation |
Modified polysaccharides having improved absorbent properties and process for the preparation thereof
|
US6262255B1
(en)
*
|
1995-04-05 |
2001-07-17 |
Biomm, Inc. |
Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them
|
US5827937A
(en)
*
|
1995-07-17 |
1998-10-27 |
Q Med Ab |
Polysaccharide gel composition
|
US5952006A
(en)
*
|
1995-09-29 |
1999-09-14 |
L.A.M. Pharmaceuticals, Llc |
Drug preparations for treating impotency
|
US6036977A
(en)
*
|
1995-09-29 |
2000-03-14 |
L.A.M. Pharmaceutical Corp. |
Drug preparations for treating sexual dysfunction
|
US6251436B1
(en)
|
1995-09-29 |
2001-06-26 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
US5897880A
(en)
*
|
1995-09-29 |
1999-04-27 |
Lam Pharmaceuticals, Llc. |
Topical drug preparations
|
US6387407B1
(en)
|
1995-09-29 |
2002-05-14 |
L.A.M. Pharmaceutical Corporation |
Topical drug preparations
|
US5716631A
(en)
*
|
1995-09-29 |
1998-02-10 |
Rdn Therapeutics Inc. |
Long acting narcotic analgesics and antagonists
|
CA2239775C
(en)
*
|
1995-12-18 |
2008-07-15 |
Collagen Corporation |
Crosslinked polymer compositions and methods for their use
|
US6833408B2
(en)
*
|
1995-12-18 |
2004-12-21 |
Cohesion Technologies, Inc. |
Methods for tissue repair using adhesive materials
|
US7883693B2
(en)
*
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
US5791352A
(en)
*
|
1996-06-19 |
1998-08-11 |
Fusion Medical Technologies, Inc. |
Methods and compositions for inhibiting tissue adhesion
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6063061A
(en)
*
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
FR2752843B1
(fr)
*
|
1996-08-30 |
1998-10-16 |
Sod Conseils Rech Applic |
Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
DE19712708A1
(de)
*
|
1997-03-26 |
1998-10-01 |
Thueringisches Inst Textil |
Getrocknete kontaminationsarme Hydrokolloide und Hydrogele
|
US20040096422A1
(en)
*
|
1997-06-17 |
2004-05-20 |
Schwartz Herbert E. |
Compositions of polyacids and polyethers and methods for their use in reducing pain
|
US6869938B1
(en)
|
1997-06-17 |
2005-03-22 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use in reducing adhesions
|
US5906997A
(en)
*
|
1997-06-17 |
1999-05-25 |
Fzio Med, Inc. |
Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
|
US7192984B2
(en)
*
|
1997-06-17 |
2007-03-20 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use as dermal fillers
|
US20050074495A1
(en)
*
|
1997-06-17 |
2005-04-07 |
Fziomed, Inc. |
Compositions of polyacids and methods for their use in reducing adhesions
|
US6229009B1
(en)
|
1997-08-29 |
2001-05-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Polycarboxylic based cross-linked copolymers
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
US6630457B1
(en)
*
|
1998-09-18 |
2003-10-07 |
Orthogene Llc |
Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
|
CA2353642C
(en)
|
1998-12-04 |
2009-11-10 |
Amarpreet S. Sawhney |
Biocompatible crosslinked polymers
|
FR2790391B1
(fr)
|
1999-03-02 |
2002-11-15 |
Flamel Tech Sa |
Moyen pour la prevention des adherences post-chirurgicales,a base de peptides collagenique reticule
|
AU3886600A
(en)
*
|
1999-03-15 |
2000-10-04 |
Trustees Of Boston University |
Angiogenesis inhibition
|
US20040048021A1
(en)
*
|
1999-03-19 |
2004-03-11 |
Wan Barbara Y. F. |
Surface modification of substrates
|
WO2000059490A2
(en)
*
|
1999-04-06 |
2000-10-12 |
Genzyme Corporation |
Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions
|
FR2799196B1
(fr)
*
|
1999-10-04 |
2002-02-08 |
Sod Conseils Rech Applic |
Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7651703B2
(en)
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
KR20020062301A
(ko)
*
|
1999-11-09 |
2002-07-25 |
덴끼 가가꾸 고교 가부시키가이샤 |
수난용성화된 가용성 셀룰로오스 유도체의 용도 및 그제조방법
|
US20030211166A1
(en)
*
|
2001-07-31 |
2003-11-13 |
Yamamoto Ronald K |
Microparticulate biomaterial composition for medical use
|
ATE283715T1
(de)
|
1999-12-17 |
2004-12-15 |
Genzyme Corp |
Chirurgische prothese
|
AU1894901A
(en)
*
|
1999-12-21 |
2001-07-03 |
Ajinomoto Co., Inc. |
Partial ester of cellulose with nitrogenous carboxylic acid and process for producing the same
|
US6566345B2
(en)
|
2000-04-28 |
2003-05-20 |
Fziomed, Inc. |
Polyacid/polyalkylene oxide foams and gels and methods for their delivery
|
US20040215231A1
(en)
*
|
2000-02-03 |
2004-10-28 |
David Fortune |
Device for the closure of a surgical puncture
|
US6521223B1
(en)
*
|
2000-02-14 |
2003-02-18 |
Genzyme Corporation |
Single phase gels for the prevention of adhesions
|
US6749865B2
(en)
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
AU2001255716B2
(en)
*
|
2000-04-28 |
2006-02-02 |
Fziomed, Inc. |
Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
|
AU2002210436A1
(en)
*
|
2000-08-02 |
2002-02-13 |
Aesculap Ag And Co. Kg |
Medical technical product, method for producing the same and providing the same for surgery
|
AU2001286701A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Genzyme Biosurgery Corporation |
Hyaluronan-based antiadhesion compositions, their preparation and use
|
KR100375299B1
(ko)
|
2000-10-10 |
2003-03-10 |
주식회사 엘지생명과학 |
히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
|
WO2002034304A1
(en)
*
|
2000-10-23 |
2002-05-02 |
Tissuemed Limited |
Self-adhesive hydratable matrix for topical therapeutic use
|
US6710162B2
(en)
*
|
2001-02-16 |
2004-03-23 |
Genzyme Corporation |
Method of drying a material having a cohesive phase
|
WO2002068383A2
(en)
*
|
2001-02-22 |
2002-09-06 |
Anika Therapeutics, Inc. |
Thiol-modified hyaluronan
|
US20020172712A1
(en)
*
|
2001-03-19 |
2002-11-21 |
Alan Drizen |
Antiemetic, anti-motion sustained release drug delivery system
|
US20030138494A1
(en)
*
|
2001-05-15 |
2003-07-24 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
AU2002367394A1
(en)
*
|
2001-12-28 |
2003-07-24 |
Genzyme Corporation |
Bioresorbable foam packing device and use thereof
|
WO2003094937A1
(en)
*
|
2002-05-09 |
2003-11-20 |
Medigenes |
A pharmaceutical composition for treatment of wounds containing blood plasma or serum
|
US7299805B2
(en)
|
2002-06-07 |
2007-11-27 |
Marctec, Llc |
Scaffold and method for implanting cells
|
CN102178692A
(zh)
*
|
2002-07-03 |
2011-09-14 |
派瑞克科学公司 |
透明质酸组合物以及使用方法
|
AU2003264498A1
(en)
*
|
2002-09-18 |
2004-04-08 |
Wakamoto Pharmaceutical Co., Ltd. |
Transparent and reversibly heat-gelling aqueous compositions
|
US8673333B2
(en)
*
|
2002-09-25 |
2014-03-18 |
The Johns Hopkins University |
Cross-linked polymer matrices, and methods of making and using same
|
US7862831B2
(en)
*
|
2002-10-09 |
2011-01-04 |
Synthasome, Inc. |
Method and material for enhanced tissue-biomaterial integration
|
US20050069572A1
(en)
*
|
2002-10-09 |
2005-03-31 |
Jennifer Elisseeff |
Multi-layered polymerizing hydrogels for tissue regeneration
|
TWI251596B
(en)
*
|
2002-12-31 |
2006-03-21 |
Ind Tech Res Inst |
Method for producing a double-crosslinked hyaluronate material
|
WO2004063181A1
(en)
|
2003-01-03 |
2004-07-29 |
Genzyme Corporation |
Urea derivatives and their use as anti-inflammatory agents
|
US7465766B2
(en)
*
|
2004-01-08 |
2008-12-16 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US8137688B2
(en)
*
|
2003-01-10 |
2012-03-20 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US8138265B2
(en)
*
|
2003-01-10 |
2012-03-20 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US6982298B2
(en)
*
|
2003-01-10 |
2006-01-03 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
BRPI0408853A
(pt)
*
|
2003-04-04 |
2006-04-04 |
Tissuemed Ltd |
formulações para adesão ao tecido
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
WO2005000374A1
(ja)
*
|
2003-06-30 |
2005-01-06 |
Denki Kagaku Kogyo Kabushiki Kaisha |
脊椎・脊髄手術用癒着防止材
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
EP1654002B2
(en)
|
2003-08-07 |
2014-01-29 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes
|
US7625581B2
(en)
*
|
2003-12-19 |
2009-12-01 |
Ethicon, Inc. |
Tissue scaffolds for use in muscoloskeletal repairs
|
US7091191B2
(en)
*
|
2003-12-19 |
2006-08-15 |
Ethicon, Inc. |
Modified hyaluronic acid for use in musculoskeletal tissue repair
|
JP2005261608A
(ja)
*
|
2004-03-18 |
2005-09-29 |
Masato Kusunoki |
薬物を担持した生体吸収性ゲル、パウダーおよびフィルム
|
ES2546393T3
(es)
|
2004-04-20 |
2015-09-23 |
Genzyme Corporation |
Implante quirúrgico tipo malla
|
NZ550964A
(en)
|
2004-04-28 |
2011-05-27 |
Angiodevice Internat Gmbh |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
EP1595528A1
(de)
*
|
2004-05-14 |
2005-11-16 |
Fibona Health Products GmbH |
Hyaferm-Komposite
|
JP4876073B2
(ja)
*
|
2004-08-03 |
2012-02-15 |
ティシュームド リミテッド |
組織接着性材料
|
US7858107B2
(en)
*
|
2004-09-10 |
2010-12-28 |
Medtronic Xomed, Inc. |
Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time
|
US8303973B2
(en)
|
2004-09-17 |
2012-11-06 |
Angiotech Pharmaceuticals (Us), Inc. |
Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
|
US20060069063A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Yng-Jiin Wang |
Crosslinked polygalacturonic acid used for postsurgical tissue adhesion prevention
|
EP1804717A4
(en)
|
2004-09-28 |
2015-11-18 |
Atrium Medical Corp |
DRUG DELIVERY COATING WHICH CAN BE USED WITH VASCULAR ENDOPROSTHESIS
|
US8312836B2
(en)
*
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
US9012506B2
(en)
*
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US8795703B2
(en)
|
2004-09-28 |
2014-08-05 |
Atrium Medical Corporation |
Stand-alone film and methods for making the same
|
WO2006056204A1
(en)
|
2004-11-24 |
2006-06-01 |
Novozymes Biopolymer A/S |
Method of cross-linking hyaluronic acid with divinylsulfone
|
CN1325125C
(zh)
*
|
2004-12-23 |
2007-07-11 |
中国人民解放军第二军医大学 |
一种防粘连生物膜
|
ITTO20040918A1
(it)
*
|
2004-12-29 |
2005-03-29 |
Luigi Ambrosio |
Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
|
WO2006089119A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Cartilix, Inc. |
Biological adhesive
|
WO2007015579A1
(ja)
|
2005-08-04 |
2007-02-08 |
Teijin Limited |
セルロース誘導体
|
US7323184B2
(en)
*
|
2005-08-22 |
2008-01-29 |
Healagenics, Inc. |
Compositions and methods for the treatment of wounds and the reduction of scar formation
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
EP1933991A4
(en)
|
2005-10-15 |
2012-05-02 |
Atrium Medical Corp |
HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
|
US20070110788A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Hissong James B |
Injectable formulation capable of forming a drug-releasing device
|
EP1979018B1
(en)
|
2006-02-03 |
2013-08-07 |
Tissuemed Limited |
Tissue-adhesive materials
|
US20090018575A1
(en)
*
|
2006-03-01 |
2009-01-15 |
Tissuemed Limited |
Tissue-adhesive formulations
|
EP2001529A4
(en)
*
|
2006-03-21 |
2011-11-09 |
Agency Science Tech & Res |
MATERIAL FOR CELLULAR ADHESION POLYELECTROLYTE FOR USE AS MEMBRANE AND COATING
|
JP2009533455A
(ja)
*
|
2006-04-12 |
2009-09-17 |
マサチューセッツ インスティテュート オブ テクノロジー |
癒着を阻害するための組成物および方法
|
US20070264296A1
(en)
*
|
2006-05-10 |
2007-11-15 |
Myntti Matthew F |
Biofilm extracellular polysachharide solvating system
|
US7976873B2
(en)
*
|
2006-05-10 |
2011-07-12 |
Medtronic Xomed, Inc. |
Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
|
US7993675B2
(en)
*
|
2006-05-10 |
2011-08-09 |
Medtronic Xomed, Inc. |
Solvating system and sealant for medical use in the sinuses and nasal passages
|
US7959943B2
(en)
*
|
2006-05-10 |
2011-06-14 |
Medtronics Xomed, Inc. |
Solvating system and sealant for medical use in the middle or inner ear
|
US8703122B2
(en)
*
|
2006-05-31 |
2014-04-22 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
US8313762B2
(en)
*
|
2006-07-05 |
2012-11-20 |
Medtronic Xomed, Inc. |
Flexible bioresorbable hemostatic packing and stent
|
TWI436793B
(zh)
*
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
ITMI20061726A1
(it)
*
|
2006-09-11 |
2008-03-12 |
Fidia Farmaceutici |
Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
EP2626091B1
(en)
|
2006-11-06 |
2016-09-28 |
Atrium Medical Corporation |
Coated surgical mesh
|
US8114159B2
(en)
|
2006-11-20 |
2012-02-14 |
Depuy Spine, Inc. |
Anterior spinal vessel protector
|
CN101605817B
(zh)
|
2007-02-06 |
2013-03-27 |
帝人株式会社 |
纤维素衍生物及其制备方法
|
JP5242921B2
(ja)
*
|
2007-02-06 |
2013-07-24 |
帝人株式会社 |
ホスファチジルエタノールアミン結合多糖類の製造方法
|
US8088095B2
(en)
*
|
2007-02-08 |
2012-01-03 |
Medtronic Xomed, Inc. |
Polymeric sealant for medical use
|
US8658148B2
(en)
|
2007-06-22 |
2014-02-25 |
Genzyme Corporation |
Chemically modified dendrimers
|
GB0715514D0
(en)
*
|
2007-08-10 |
2007-09-19 |
Tissuemed Ltd |
Coated medical devices
|
MX2010004838A
(es)
|
2007-10-30 |
2010-05-21 |
Baxter Int |
Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales.
|
SI2818184T1
(sl)
|
2007-11-16 |
2019-03-29 |
Aclaris Therapeutics, Inc. |
Sestava in postopki za zdravljenje purpure
|
US9345809B2
(en)
|
2007-11-28 |
2016-05-24 |
Fziomed, Inc. |
Carboxymethylcellulose polyethylene glycol compositions for medical uses
|
US8394782B2
(en)
*
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
EP2222715B1
(en)
*
|
2007-12-19 |
2019-07-24 |
Evonik Degussa GmbH |
Crosslinked hyaluronic acid in emulsion
|
US8080260B2
(en)
|
2008-02-13 |
2011-12-20 |
The Cleveland Clinic Foundation |
Molecular enhancement of extracellular matrix and methods of use
|
US8668863B2
(en)
|
2008-02-26 |
2014-03-11 |
Board Of Regents, The University Of Texas System |
Dendritic macroporous hydrogels prepared by crystal templating
|
US8642831B2
(en)
|
2008-02-29 |
2014-02-04 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
EP2300042A4
(en)
*
|
2008-04-30 |
2012-05-02 |
Cleveland Clinic Foundation |
COMPOSITIONS AND METHODS FOR TREATING URINARY INCONTINENCE
|
WO2009148985A2
(en)
*
|
2008-06-03 |
2009-12-10 |
E. I. Du Pont De Nemours And Company |
A tissue coating for preventing undesired tissue-to-tissue adhesions
|
EP2303254B1
(en)
|
2008-06-12 |
2019-10-30 |
Medtronic Xomed, Inc. |
Product for treating chronic wounds with an extracellular polymeric substance solvating system
|
US8357795B2
(en)
|
2008-08-04 |
2013-01-22 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
US20110178184A1
(en)
*
|
2008-08-05 |
2011-07-21 |
Teijin Limited |
Hydrogel
|
EP3184552B1
(en)
|
2008-09-02 |
2020-08-12 |
Tautona Group LP |
Threads of hyaluronic acid, methods of making thereof and uses thereof
|
WO2010042427A2
(en)
|
2008-10-06 |
2010-04-15 |
Microbial Defense Systems, Llc |
Antimicrobial composition and methods of making and using same
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
PT2442835E
(pt)
*
|
2009-06-16 |
2015-03-23 |
Baxter Healthcare Sa |
Esponja hemostática
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
JP2013514093A
(ja)
|
2009-12-16 |
2013-04-25 |
バクスター・インターナショナル・インコーポレイテッド |
止血スポンジ
|
EP2522374B1
(en)
|
2009-12-28 |
2015-08-19 |
Kawasumi Laboratories, Inc. |
Anti-adhesion material
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
EP2544652A2
(en)
|
2010-03-12 |
2013-01-16 |
Allergan Industrie SAS |
A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
|
CA2794254C
(en)
|
2010-03-22 |
2018-09-04 |
Allergan, Inc. |
Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
CA2801118C
(en)
|
2010-06-01 |
2016-01-05 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
MX352875B
(es)
|
2010-06-01 |
2017-12-13 |
Baxter Healthcare Sa |
Proceso para elaborar composiciones hemostaticas secas y estables.
|
AU2011260258B2
(en)
|
2010-06-01 |
2015-07-09 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
WO2012048289A1
(en)
|
2010-10-08 |
2012-04-12 |
Board Of Regents, The University Of Texas System |
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
|
US8946194B2
(en)
|
2010-10-08 |
2015-02-03 |
Board Of Regents, University Of Texas System |
One-step processing of hydrogels for mechanically robust and chemically desired features
|
BR112013028673B1
(pt)
|
2011-05-10 |
2020-06-16 |
Next Science IP Holdings Pty Ltd |
Sólido antimicrobiano e métodos de fazer e usar o mesmo
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
WO2012167079A2
(en)
|
2011-06-03 |
2012-12-06 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
HUE056131T2
(hu)
|
2011-08-10 |
2022-01-28 |
Glycores 2000 Srl |
Lebomlásra ellenálló, kereszt-kötött, kis molekulatömegû hialuronát
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
US20130096063A1
(en)
|
2011-10-11 |
2013-04-18 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
KR102135484B1
(ko)
|
2011-10-11 |
2020-07-20 |
백스터 인터내셔널 인코포레이티드 |
지혈 조성물
|
US20130108671A1
(en)
|
2011-10-27 |
2013-05-02 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
US11109849B2
(en)
|
2012-03-06 |
2021-09-07 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
FR2988585B1
(fr)
|
2012-03-28 |
2015-04-03 |
Cousin Biotech |
Plaque viscerale destinee a la coelioscopie
|
RU2636240C2
(ru)
|
2012-06-12 |
2017-11-21 |
Ферросан Медикал Дивайсиз А/С |
Сухая гемостатическая композиция
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
US11565027B2
(en)
|
2012-12-11 |
2023-01-31 |
Board Of Regents, The University Of Texas System |
Hydrogel membrane for adhesion prevention
|
WO2014093489A2
(en)
|
2012-12-11 |
2014-06-19 |
Board Of Regents, The University Of Texas System |
Hydrogel membrane for adhesion prevention
|
EP2950783B1
(en)
|
2013-02-01 |
2019-05-15 |
Allergan, Inc. |
Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
|
US20140315828A1
(en)
|
2013-04-22 |
2014-10-23 |
Allergan, Inc. |
Cross-linked silk-hyaluronic acid compositions
|
US9724078B2
(en)
|
2013-06-21 |
2017-08-08 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
US10111980B2
(en)
|
2013-12-11 |
2018-10-30 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
EP3200838B1
(en)
|
2014-09-30 |
2019-09-18 |
Allergan Industrie, SAS |
Stable hydrogel compositions including additives
|
RU2715235C2
(ru)
|
2014-10-13 |
2020-02-26 |
Ферросан Медикал Дивайсиз А/С |
Сухая композиция для использования при гемостазе и заживлении ран
|
JP6747650B2
(ja)
|
2014-12-24 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
第1の物質と第2の物質を保持し混合するためのシリンジ
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
CN107771093B
(zh)
|
2015-07-03 |
2021-06-15 |
弗罗桑医疗设备公司 |
用于混合两种组分和用于在存储条件下保持真空的注射器
|
CN105381501A
(zh)
*
|
2015-12-15 |
2016-03-09 |
日照天一生物医疗科技有限公司 |
可降解生物复合止血膜及其制备方法
|
US10300169B2
(en)
|
2016-08-24 |
2019-05-28 |
Allergan, Inc. |
Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
|
WO2018165327A1
(en)
|
2017-03-08 |
2018-09-13 |
Alafair Biosciences, Inc. |
Hydrogel medium for the storage and preservation of tissue
|
MX2020011866A
(es)
|
2018-05-09 |
2021-01-20 |
Ferrosan Medical Devices As |
Metodo para preparar una composicion hemostatica.
|
JP7396804B2
(ja)
*
|
2019-03-01 |
2023-12-12 |
大日本印刷株式会社 |
ゲル膜の製造方法およびゲル膜
|
JP7311983B2
(ja)
*
|
2019-03-01 |
2023-07-20 |
大日本印刷株式会社 |
ゲル膜の製造方法およびゲル膜
|
RU2744752C1
(ru)
*
|
2020-08-28 |
2021-03-15 |
Федеральное государственное бюджетное учреждение науки Институт проблем химико-энергетических технологий Сибирского отделения Российской академии наук (ИПХЭТ СО РАН) |
Способ получения противоспаечного материала
|
US11980699B2
(en)
|
2021-09-01 |
2024-05-14 |
Shanghai Qisheng Biological Preparation Co., Ltd. |
Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
|
WO2023056433A1
(en)
*
|
2021-10-01 |
2023-04-06 |
Northwestern University |
Supramolecular-covalent composite slurry for cartilage repair
|